Review article: The continuing dilemma of dyspepsia

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 14, Issue 3, 2000, Pages 23-30

  Stanghellini, V ^a   Tosetti, C ^a   Barbara, G ^a   De Giorgio, R ^a   Salvioli, B ^a   Corinaldesi, R ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST;

ANAMNESIS; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DYSPEPSIA; ENDOSCOPY; ERADICATION THERAPY; GASTROESOPHAGEAL REFLUX; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; PEPTIC ULCER; PRIORITY JOURNAL; STOMACH CANCER; SYMPTOMATOLOGY;

DYSPEPSIA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMAN;

EID: 0033783556     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (56)

1. Management of nonulcer dyspepsia
2. Functional gastroduodenal disorders
3. Widespread eradication of Helicobacter pylori: A debate against
4. Identification of distinct upper and lower gastrointestinal symptoms groupings in the urban population
5. Symptoms in gastro-oesophageal reflux disease
6. A Canadian physician survey of dyspepsia management
7. Management of dyspepsia in primary care: Dyspepsia subgroups are useful in determining treatment
8. Predominant symptoms identify different subgroups in functional dyspepsia
9. Role of impaired gastric accomodation to a meal in functional dyspepsia
10. Efficacy of omeprazole in functional dyspepsia. Double-blind, randomized, placebo controlled trials (the Bond and Opera studies)
11. Responses to consecutive patients to reassurance after gastroscopy: Results of self administered questionnaire survey
12. Endoscopy in the evaluation of dyspepsia
13. The Steering Group of Upper Gastrointestinal Endoscopy Audit Committee. Appropriate use of upper gastrointestinal endoscopy - A prospective audit
14. Prognosis of dyspepsia among patients in general practice. The consequence of having one or more alarm symptoms
15. The yield of prospective endoscopic gastro-intestinal evaluation in patients with low (<50 ng/ml) ferritin
16. Clinical presentation of patients with 'dyspepsia'
17. A database on dyspepsia
18. Chronic dyspepsia: Who needs endoscopy?
19. The predictive value of history in dyspepsia
20. Risk indicators of organic disease in uninvestigated dyspepsia: A one-week survey in 246 endoscopic units
21. Etiology of dyspepsia: Four hundred unselected consecutive patients in general practice
22. The diagnostic outcome of upper gastrointestinal endoscopy: Are referral source and patient age determining factors?
23. Dyspepsia: A dilemma for doctors?
24. Prospective screening of dyspeptic patients by Helicobacter pylori serology
25. Risk factors, co-medication, and concomitant diseases: Their influence on the outcome of therapy with cisapride
26. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration
27. Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia
28. Natural history of dyspepsia in primary care and factors associated with patient satisfaction with health care
29. What happens to patients with non-ulcer dyspepsia after endoscopy?
30. The Helicobacter pylori breath test: A surrogate marker for peptic ulcer disease in dyspeptic patients
31. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia
32. Alternative management strategies for patients with suspected peptic ulcer disease
33. Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: Clinical and economic consequences
34. Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: A decision analysis
35. Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age
36. Cost-benefit analysis of testing for Helicobacter pylori in dyspeptic subjects
37. IgG ELISA antibodies and detection of Helicobacter pylori in the elderly
38. How should Helicobacter pylori be managed?
39. The crisis in antibiotic resistance
40. Heartburn - A serious disease
41. A critique of therapeutic trials on Helicobacter pyloripositive functional dyspepsia
42. Eradication of Helicobacter pylori affects symptoms in non-ulcer dyspepsia
43. Lack of effect of treating Helicobacter pylori infection in patients with non-ulcer dyspepsia
44. Is Helicobacter pylori associated with non-ulcer dyspepsia and will eradication improve symptoms? A meta-analysis
45. Eradication of Helicobacter pylori in functional dyspepsia: Randomised double-blind placebo controlled trial with 12 months' follow up
46. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia
47. On duodenal ulcer: With notes of 52 operations
48. Dyspepsia. Incidence of non-ulcer disease in a controlled trial of ranitidine in general practice
49. Chronic dyspepsia pain in general practice. Its cause and diagnosis
50. The clinical benefit of upper gastrointestinal endoscopy in dyspepsia
51. Management of dyspeptic patients in primary care. Value of the unaided clinical diagnosis and of dyspepsia subgrouping
52. Long term acid suppressing treatment in general practice
53. Drug treatment of functional dyspepsia - A meta-analysis of randomized controlled trials
54. Cisapride or cimetidine in the treatment of functional dyspepsia - Results of a double-blind, randomised, Swiss multicentre study
55. Pattern of symptoms in functional dyspepsia: Predictors of a response to treatment?
56. Fasting and postprandial gastrointestinal motility in ulcer and non-ulcer dyspepsia